International Journal of Gynecology & Obstetrics
Volume 86, Supplement , Pages S53-S62, July 2004

Duloxetine: a new approach for treating stress urinary incontinence☆

  • Kate Moore

      Affiliations

    • Corresponding Author InformationTel.: +61-2-9350-2054; fax: +61-2-9350-3951

St. George Hospital, University of New South Wales, Pelvic Floor Unit, 1st Floor, Pitney Clinical Sciences Building, Kogarah, New South Wales 2217, Sydney, Australia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Duloxetine, a potent and balanced dual serotonin and norepinephrine reuptake inhibitor, is an effective and safe pharmacological therapy as shown in one phase 2 and three phase 3 placebo-controlled clinical trials involving approximately 2000 women with SUI.

PII: S0020-7292(04)00183-3

doi:10.1016/j.ijgo.2004.05.009

International Journal of Gynecology & Obstetrics
Volume 86, Supplement , Pages S53-S62, July 2004

Article Tools

* Image Usage & Resolution